Table 1.
Second Primary Cancer Sites | Standard Incidence Ratio | 95% Confidence Interval |
---|---|---|
All sites | 1.42 | 1.39–1.44 |
Soft tissue sarcoma* | 10.75 | 8.16–13.89 |
Bone | 2.66 | 1.73–3.89 |
Myeloid leukaemia | 2.11 | 1.78–2.49 |
Esophagus | 2.09 | 1.80–2.42 |
Thyroid gland | 1.86 | 1.57–2.19 |
Skin cancer except for melanoma | 1.77 | 1.67–1.87 |
Ovary | 1.75 | 1.63–1.88 |
Lung | 1.68 | 1.59–1.78 |
Stomach | 1.49 | 1.38–1.62 |
Leukemia | 1.43 | 1.28–1.60 |
Corpus uteri | 1.40 | 1.30–1.50 |
Oral cavity and pharynx | 1.40 | 1.21–1.61 |
Melanoma | 1.39 | 1.25–1.54 |
Non-Hodgkin’s lymphoma | 1.39 | 1.26–1.54 |
Pancreas | 1.32 | 1.20–1.44 |
Colorectal | 1.30 | 1.24–1.36 |
Bladder | 1.30 | 1.17–1.45 |
Kidney | 1.27 | 1.14–1.42 |
Notes: *Soft tissue sarcoma of the upper limbs and chest including the shoulders. Reproduced wih permission from Mellemkjaer L, Friis S, Olsen JH, et al. Risk of second cancer among women with breast cancer. Int J Cancer.. 2005;118(9):2285–2292. Copyright © 2005 Wiley‐Liss, Inc.4